In most corporate settings, operations functions provide reliability and continuity in the discipline they support. In sales, it ensures smooth pipeline progression, manages customer relationship management (CRM) data integrity, and administers compensation systems. In finance, operations handle controls, reporting, and compliance routines. These functions thrive on repeatable processes, data visibility, and accountability systems.
Within alliance management, particularly in information technology firms with diverse and large partner ecosystems, operations are often run as a program office that manages the structured way in which these firms organize their partnering. For volume-based partner segments, it supports new partner evaluation, onboarding, program compliance, rewards and incentives, and scalable enablement. These models have created a template for operational support that aligns with repeat interactions across partner types.
However, biopharma strategic alliances are inherently more variable. Operational complexity is driven not by partner volume but by the degree of collaboration required between the partners, especially joint responsibility for stages of the drug lifecycle, contract terms, scientific uncertainty, and the sheer number of functions, territories, and stakeholders involved.
Unlike the large partner programs common in information technology companies, every biopharma alliance is individually negotiated. And yet, even here, an operations function can help bring reliability and continuity to alliance management across a diverse portfolio of collaborations.
Download the full paper written with our partners at The Rhythm of Business to read on (no questions asked!)...